⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39
globenewswire.com
LRCX
LLY
Chai Discovery Announces Collaboration with Eli Lilly and Company to Accelerate Biologics Discovery
businesswire.com
LLY
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Alamar Biosciences for the Transformative Bio-Hermes Studies
globenewswire.com
BIIB
LLY
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer
globenewswire.com
MGNX
IMTX
LLY
PFE
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
businesswire.com
RVTY
LLY
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc. - VTYX
prnewswire.com
VTYX
LLY
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight
prnewswire.com
LLY
WORLDLINE : EGM results - Press release
globenewswire.com
JPM
BAC
WFC
MS
GS
AXP
PYPL
V
MA
CMCSA
T
VZ
IBM
ORCL
SAP
ACN
ADP
PAYX
FIS
FDS
EVO
PSFE
LCID
RIVN
NIO
XPEV
TSLA
GM
F
STLA
CRDO
ADBE
GOOG
AMZN
META
NVDA
INTC
AMD
QCOM
CRM
NFLX
DIS
CMG
MCD
SBUX
PEP
KO
PG
JNJ
PFE
MRK
ABBV
AMGN
GILD
BMY
LLY
UNH
CVS
XOM
CVX
SHEL
BABA
JD
PDD
NTES
BIDU
AMTD
CPT
CA
BP
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
businesswire.com
PCAR
ESPR
PRTA
LLY
CRBU
RAPT
Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatology, Dermatology and JAK/STAT Biology
globenewswire.com
SCLZ
LLY
SNY